Ocrelizumab-assoziierte schwere Neutropenie: eine unterschätzte Komplikation der Therapie mit CD20-Antikörpern bei Multipler Sklerose?

Translated title of the contribution: Ocrelizumab-associated severe neutropenia: an underestimated complication of treatment of multiple sclerosis with anti-CD20 antibodies?

Felix Hess, Paula Uibel, Achim Berthele, Bernhard Hemmer

Research output: Contribution to journalComment/debate

Translated title of the contributionOcrelizumab-associated severe neutropenia: an underestimated complication of treatment of multiple sclerosis with anti-CD20 antibodies?
Original languageGerman
Pages (from-to)1153-1156
Number of pages4
JournalNervenarzt
Volume94
Issue number12
DOIs
StatePublished - Dec 2023
Externally publishedYes

Cite this